Tiempo real estimado
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
15,2 USD | +0,96 % | +2,17 % | -10,47 % |
Resumen de negocios
Número de empleados: 167
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Drug Products
100,0
%
| 214 | 100,0 % | 398 | 100,0 % | +85,90 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 214 | 100,0 % | 398 | 100,0 % | +85,90 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Patrick McEnany
FOU | Founder | 77 | 01/01/02 |
Richard Daly
CEO | Chief Executive Officer | 62 | 19/02/15 |
Michael Kalb
DFI | Director of Finance/CFO | 53 | 01/01 |
Stanley Iyadurai
CTO | Chief Tech/Sci/R&D Officer | - | 20/08/18 |
Brian Elsbernd
CMP | Compliance Officer | 60 | 29/02/16 |
Steven Miller
COO | Chief Operating Officer | 62 | 01/04/07 |
Gary Ingenito
CTO | Chief Tech/Sci/R&D Officer | 68 | 01/06/15 |
Charles O'Keeffe
BRD | Director/Board Member | 84 | 01/12/04 |
Mary Coleman
IRC | Investor Relations Contact | - | 16/08/21 |
Preethi Sundaram
PRN | Corporate Officer/Principal | 47 | 06/07/21 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Patrick McEnany
FOU | Founder | 77 | 01/01/02 |
Donald Denkhaus
BRD | Director/Board Member | 78 | 19/02/15 |
David Tierney
BRD | Director/Board Member | 60 | 01/10/02 |
Charles O'Keeffe
BRD | Director/Board Member | 84 | 01/12/04 |
Richard Daly
CEO | Chief Executive Officer | 62 | 19/02/15 |
Molly Harper
BRD | Director/Board Member | 48 | 29/06/21 |
Tamar Thompson
BRD | Director/Board Member | 50 | 25/05/23 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 118 011 092 | 110 678 237 ( 93,79 %) | 0 | 93,79 % |
Participaciones
Nombre | Acciones | % | Valoración |
---|---|---|---|
1 414 688 | 11.21% | 15 345 290 $ |
Información de la empresa
Catalyst Pharmaceuticals, Inc.
355 Alhambra Circle Suite 801
33134, Coral Gables
+305 420 3200
http://www.catalystpharma.comRevisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
-10,47 % | 1776,07 M | |
-4,24 % | 86,85 mil M | |
+2,76 % | 40,16 mil M | |
-16,98 % | 31,28 mil M | |
+57,86 % | 25,27 mil M | |
-16,24 % | 15,33 mil M | |
-9,12 % | 11,96 mil M | |
-42,56 % | 11,61 mil M | |
+6,89 % | 8831,13 M | |
-10,53 % | 7935,63 M |
- Bolsa de valores
- Acciones
- Acción CPRX
- Empresa Catalyst Pharmaceuticals, Inc.